Press Coverage

Patient story: Cellvizio was used to speed up diagnosis and to enable faster treatment and care

19 November 2014

Ben Carlsen is 36 years old and has been living with lung cancer for the last six months. He was referred to Dr. Aki at the Lung Center at Valley View where he experienced technology that combines detection, diagnosis and staging in one procedure. A GPS-like technology was used to locate, test and detect a lesion in the lung, and Cellvizio Confocal Endomicroscopy enabled his pulmonologist to see individual cells in the farthest reaches of his lungs.

Latest News

Mauna Kea Technologies Announces its Sales and Achievements For the Second Quarter 2024

Mauna Kea Technologies Announces its Sales and Achievements For the Second Quarter 2024

Mauna Kea Technologies Unveils CellTolerance, a Subsidiary Dedicated to its Unique Program for the Detection and Treatment of Food Intolerances

Mauna Kea Technologies Unveils CellTolerance, a Subsidiary Dedicated to its Unique Program for the Detection and Treatment of Food Intolerances

Mauna Kea Technologies Reports New Evidence Highly Supportive of the Use of Cellvizio for Diagnosing Pancreatic Cysts Presented at DDW 2024

Mauna Kea Technologies Reports New Evidence Highly Supportive of the Use of Cellvizio for Diagnosing Pancreatic Cysts Presented at DDW 2024